Haemolytic disease of the newborn: the new NICE guidelines.
This article looks at the epidemiology of rhesus D, the clinical manifestations of haemolytic disease of the newborn and recent NICE guidelines on prevention. All pregnant women should be offered prophylactic anti-rhesus D immunoglobulin as part of normal antenatal care if they are rhesus-D negative and free from Rh-D antibodies.
Thompson
June
J
D004899:Erythroblastosis, Fetal / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007518:Isoantibodies / Q000627:therapeutic use*; D008431:Maternal-Fetal Exchange; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011295:Prenatal Care; D012203:Rh Isoimmunization / Q000517:prevention & control*; D018029:Rho(D) Immune Globulin
D007518:Isoantibodies; C061961:RHO(D) antibody; D018029:Rho(D) Immune Globulin